Why this matters — Three distinct ORTEX data streams have aligned on EUDA within 48 hours. Short interest, cost to borrow, and utilisation all hit extreme levels simultaneously — a rare convergence for a micro-cap health care name.
Short Interest Explosion Short shares surged 2,518% in a single day on April 23, from 2,883 to 75,470. By April 24, shares short nearly doubled again to 163,180 — a one-day rise of 116%. Over the week, short interest is up 2,702%.
Cost to Borrow at Extreme Levels CTB hit 355.88% APR on April 24. That is up 103% in one week and 249% over one month. A month ago the rate sat near 102%. Borrowing EUDA shares now carries a severe annualised cost.
Utilisation at 52-Week High Utilisation reached 93.44% on April 24 — the highest reading in 52 weeks. It was sitting below 50% as recently as April 17. The jump of over 40 percentage points in one week shows borrowable supply is nearly fully deployed.
EUDA's ORTEX short score stands at 68.8 as of April 23, up sharply from 55.5 on April 13. Its utilisation ranks in the 3rd percentile of all stocks — meaning almost no other stock has higher relative utilisation. The short score ranks in the 5th percentile. Earnings are confirmed for April 29 — two days away. Prior earnings events produced moves of -28% and +19% on the day respectively. That upcoming catalyst adds urgency to the current positioning picture.
In mid-March 2026, EUDA saw a similar burst — short shares reached 249,080 on March 20 and CTB was already climbing past 100%. That episode resolved with a sharp unwind: by March 23, short shares had collapsed to 11,779. The current build is starting from a much lower base and is moving faster.
See the live data behind this article on ORTEX.
Open EUDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
